UBC

Sanofi teams up with Medco Health Solutions, UBC

Friday, June 24, 2011

Sanofi is looking for more ‘real-world’ insight into its drug development and product lifecycle strategies by teaming up with pharmacy benefit manager Medco Health Solutions to help deliver value propositions that can withstand tough scrutiny from regulators and payers, reports PharmaTimes.

[Read More]

Cimzia shows positive results in RA patients

Tuesday, May 10, 2011

UCB published results from a post hoc analysis of the RAPID 2 study in the Annals of Rheumatic Diseases, which showed Cimzia, the only approved PEGylated anti-TNF, plus methotrexate (MTX) provided rapid relief from a broad range of symptoms associated with the burden of moderate to severe active rheumatoid arthritis (RA). Adult patients treated with Cimzia that achieved early responses were found to have an increased chance of achieving longer-term outcomes.

[Read More]

UBC Secures additional $150 million

Wednesday, July 7, 2010

United BioSource Corporation (UBC), a global scientific and medical affairs organization based in Bethesda, Md., has secured a new line of credit that provides the company with up to $150 million in additional financing for acquisitions and other significant growth investments. Wells Fargo, PNC Bank, Capital One and JPMorgan Chase participated in financing the new credit facility.

[Read More]